Home/Filings/4/0001209191-06-004087

4//SEC Filing

SCHRODER VENTURES MANAGERS INC 4

Accession 0001209191-06-004087

CIK 0000913275other

View on SEC.gov Company Profile

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 12:41 PM ET

Size

26.5 KB

Accession

0001209191-06-004087

Insider Transaction Report

Form 4

Period: 2006-01-17

Solexa, Inc.SLXA

SCHRODER VENTURE MANAGERS LTD

10% Owner

Transactions

Sale
Common Stock
2006-01-17$11.34/sh−7,014$79,539→ 53,979 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−243,901$2,765,837→ 1,877,019 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−3,763$42,672→ 28,957 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−30,041$340,665→ 231,191 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−103,876$1,177,954→ 799,414 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−27,683$313,925→ 213,039 total(indirect: See Footnote)

Schroder Ventures International Life Sciences Fund II L.P.2

10% Owner

Transactions

Sale
Common Stock
2006-01-17$11.34/sh−103,876$1,177,954→ 799,414 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−27,683$313,925→ 213,039 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−3,763$42,672→ 28,957 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−7,014$79,539→ 53,979 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−30,041$340,665→ 231,191 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−243,901$2,765,837→ 1,877,019 total(indirect: See Footnote)

Schroder Ventures International Life Sciences Fund II L.P.3

10% Owner

Transactions

Sale
Common Stock
2006-01-17$11.34/sh−27,683$313,925→ 213,039 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−7,014$79,539→ 53,979 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−103,876$1,177,954→ 799,414 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−3,763$42,672→ 28,957 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−30,041$340,665→ 231,191 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−243,901$2,765,837→ 1,877,019 total(indirect: See Footnote)

SITCO Nominees Ltd. VC 01903 as Nominee of Schroder Ventures International Life Sciences Fund II Group Co-Investment Scheme

10% Owner

Transactions

Sale
Common Stock
2006-01-17$11.34/sh−243,901$2,765,837→ 1,877,019 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−7,014$79,539→ 53,979 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−3,763$42,672→ 28,957 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−27,683$313,925→ 213,039 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−103,876$1,177,954→ 799,414 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−30,041$340,665→ 231,191 total(indirect: See Footnote)

Schroder Ventures International Life Sciences Fund II Strategic Partners L.P.

10% Owner

Transactions

Sale
Common Stock
2006-01-17$11.34/sh−27,683$313,925→ 213,039 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−243,901$2,765,837→ 1,877,019 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−103,876$1,177,954→ 799,414 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−30,041$340,665→ 231,191 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−3,763$42,672→ 28,957 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−7,014$79,539→ 53,979 total(indirect: See Footnote)

SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1

10% Owner

Transactions

Sale
Common Stock
2006-01-17$11.34/sh−243,901$2,765,837→ 1,877,019 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−30,041$340,665→ 231,191 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−3,763$42,672→ 28,957 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−103,876$1,177,954→ 799,414 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−7,014$79,539→ 53,979 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−27,683$313,925→ 213,039 total(indirect: See Footnote)

SCHRODER VENTURES MANAGERS INC

10% Owner

Transactions

Sale
Common Stock
2006-01-17$11.34/sh−243,901$2,765,837→ 1,877,019 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−7,014$79,539→ 53,979 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−103,876$1,177,954→ 799,414 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−3,763$42,672→ 28,957 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−27,683$313,925→ 213,039 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−30,041$340,665→ 231,191 total(indirect: See Footnote)

SV (Nominees) LTD as Nominee of Schroder Ventures Investments LTD

10% Owner

Transactions

Sale
Common Stock
2006-01-17$11.34/sh−7,014$79,539→ 53,979 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−30,041$340,665→ 231,191 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−3,763$42,672→ 28,957 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−103,876$1,177,954→ 799,414 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−243,901$2,765,837→ 1,877,019 total(indirect: See Footnote)
Sale
Common Stock
2006-01-17$11.34/sh−27,683$313,925→ 213,039 total(indirect: See Footnote)

Footnotes (7)

[F1]These shares are owned directly by Schroder Ventures International Life Sciences Fund II L.P.1 ("ILSF LP1"). Schroder Venture Mangers Inc. ("SVMI"), the general partner of ILSF LP1, and Schroder Venture Managers Limited ("SVML"), fund manager to SVMI, may be deemed to share voting and dispositive power over the shares held by ILSF LP1. SVMI and SVML disclaim beneficial ownership of shares held by ILSF LP1 except to the extent of any pecuniary interest therein.
[F2]These shares are owned directly by Schroder Ventures International Life Sciences Fund II L.P.2 ("ILSF LP2"). SVMI, the general partner of ILSF LP2, and SVML, fund manager to SVMI, may be deemed to share voting and dispositive power over shares held by ILSF LP2. SVMI and SVML disclaim beneficial ownership of shares held by ILSF LP2 except to the extent of any pecuniary interest therein.
[F3]These shares are owned directly by Schroder Ventures International Life Sciences Fund II L.P.3 ("ILSF LP3"). SVMI, the general partner of ILSF LP3, and SVML, fund manager to SVMI, may be deemed to share voting and dispositive power over the shares held by ILSF LP3. SVMI and SVML disclaim beneficial ownership of shares held by ILSF LP3 except to the extent of any pecuniary interest therein.
[F4]These shares are owned directly by SITCO Nominees Ltd. - VC 01903 as Nominee for Schroder Ventures International Life Sciences Fund II Group Co-Investment Scheme ("Co-Invest"). SVMI and SVML, fund manager to SVMI, may be deemed to share voting and dispositive power over the shares held by Co-Invest because of a certain contractual relationship between Co-Invest and SVMI. SVMI and SVML disclaim beneficial ownership of shares held by Co-Invest except to the extent of any pecuniary interest therein.
[F5]These shares are held directly by SV (Nominees) Limited as Nominee for Schroder Ventures Investment Limited ("SVIL"). SVMI and SVML, fund manager to SVMI, may be deemed to share voting and dispositive power over shares held by SVIL because of a certain contractual relationship between SVIL and SVMI. SVMI and SVML disclaim beneficial ownership of shares held by SVIL except to the extent of any pecuniary interest therein.
[F6]These shares are owned directly by Schroder Ventures International Life Sciences Fund II Strategic Partners L.P. ("Strategic Partners" and together with ILSF LP1, ILSF LP2, ILSF LP3, Co-Invest and SVIL, the "Funds"). SVMI, the general partner of Strategic Partners, and SVML, fund manager to SVMI, may be deemed to share voting and dispositive power over the shares held by Strategic Partners. SVMI and SVML disclaim beneficial ownership of shares held by Strategic Partners except to the extent of any pecuniary interest therein.
[F7]Each Fund may be deemed to beneficially own the shares held by the other Funds because of certain contractual relationships among the Funds and their affiliates. Each Fund disclaims beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein.

Documents

1 file

4
b58664si.xmlPrimary
MAIN DOCUMENT DESCRIPTION

Issuer

Solexa, Inc.

CIK 0000913275

→

Entity typeother

Related Parties

filerCIK 0001002632

Filing Metadata

Form type: 4
Filed: Jan 18, 7:00 PM ET
Accepted: Jan 19, 12:41 PM ET
Size: 26.5 KB

View on SEC.gov